RE:Risk to rewardAgree. And we will also have 2 other potential deals on the horizon, in massive markets.
The company mentioned to me in response to a question that working with Abbvie has been a completely professional experience. The real McCoy.
Sirona has a reputation now of being able to deal very effectively with a Top 5 pharma. It can do it, and do it again and again. Others are certainly paying attention, fact.
The 2022-23 years is going to be a significant one, in my humble opinion.